Federation des caisses Desjardins du Quebec Has $14.26 Million Holdings in Henry Schein, Inc. $HSIC

Key Points

• The Federation des caisses Desjardins du Quebec increased its stake in Henry Schein, Inc. by 81.1% during the first quarter, now owning 208,048 shares valued at approximately $14.26 million.
• Recent analyst ratings reflect mixed sentiments, with Evercore ISI upgrading Henry Schein to an "outperform" rating, while UBS Group lowered its target price from $75.00 to $70.00.
• Henry Schein reported a quarterly EPS of $1.10, missing the consensus estimate, while revenue was up 3.3% compared to the previous year.

Federation des caisses Desjardins du Quebec raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 81.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 208,048 shares of the company's stock after buying an additional 93,158 shares during the quarter. Federation des caisses Desjardins du Quebec owned 0.17% of Henry Schein worth $14,259,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of HSIC. Investment Management Corp VA ADV purchased a new stake in Henry Schein during the fourth quarter valued at about $32,000. Rakuten Securities Inc. purchased a new stake in shares of Henry Schein in the first quarter worth approximately $34,000. Whittier Trust Co. lifted its position in shares of Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after purchasing an additional 700 shares in the last quarter. Quarry LP purchased a new stake in shares of Henry Schein in the first quarter worth approximately $71,000. Finally, UMB Bank n.a. lifted its position in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Price Performance

NASDAQ HSIC traded up $1.65 on Friday, hitting $69.43. 1,360,668 shares of the company were exchanged, compared to its average volume of 1,598,436. The firm has a 50 day moving average of $69.92 and a two-hundred day moving average of $69.74. The company has a market cap of $8.42 billion, a P/E ratio of 22.40, a P/E/G ratio of 2.29 and a beta of 0.86. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business's revenue for the quarter was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday, August 6th. JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research report on Thursday, August 7th. Barrington Research reduced their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday, August 6th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Finally, Stifel Nicolaus reaffirmed a "hold" rating and set a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.